Markets · 1 sources covering this

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

MarketWatchCenter·2h ago
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.
Read at MarketWatch →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/31739b81116dbc670b2a22ca06ab804a2e69a96a"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?"></iframe>

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

How 1 sources are covering this

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

More from Markets

Alphabet’s stock drops as Google loses another key AI executive

BC Partners’ Credit Arm Explores Extending Lifeline to LIV Golf

Boeing-Lockheed Rocket Joint Venture Taps Private Bond Market

Colombia Seizes Explosives Ahead of De la Espriella Inauguration

Reader

Trust & legal

Across the network

How 1 sources are covering this

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

More from Markets

Alphabet&#x2019;s stock drops as Google loses another key AI executive

BC Partners’ Credit Arm Explores Extending Lifeline to LIV Golf

Boeing-Lockheed Rocket Joint Venture Taps Private Bond Market

Colombia Seizes Explosives Ahead of De la Espriella Inauguration

Reader

Trust & legal

Across the network

Alphabet’s stock drops as Google loses another key AI executive